| Heller S, Koenen C, Bode B
Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial. [JOURNAL ARTICLE]
Clin Ther 2009 Oct; 31(10):2086-2097.
Abstract | Full Citation | Find Related Articles | | Cooke CE, Lee HY, Tong YP, et al.
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Nov 18.
Abstract | Full Citation | | McAdam-Marx C, Yu J, Bouchard J, et al.
Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Nov 18.
Abstract | Full Citation | | Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citation | | Swinnen SG, Snoek FJ, Dain MP, et al.
Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes. [Journal Article, Research Support, Non-U.S. Gov't]
Diabetes Technol Ther 2009 Nov; 11(11):739-43.
Abstract | Full Citation | | Misurski D, Lage MJ, Fabunmi R, et al.
A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine. [Journal Article]
Appl Health Econ Health Policy 2009; 7(4):245-54.
Abstract | Full Citation | Find Related Articles | | Arutchelvam V, Heise T, Dellweg S, et al.
Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins. [Journal Article, Research Support, Non-U.S. Gov't]
Diabet Med 2009 Oct; 26(10):1027-32.
Abstract | Full Citation | | Lee LJ, Yu AP, Johnson SJ, et al.
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysis. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2009 Nov 4.
Abstract | Full Citation | Find Related Articles | | Christiansen JS, Liebl A, Davidson JA, et al.
Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control. [JOURNAL ARTICLE]
Diabetes Obes Metab 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Arnold JJ, Fyrberg MD, Meezan E, et al.
Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside. [JOURNAL ARTICLE]
J Pharm Sci 2009 Nov 5.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
